BridgeBio Pharma LLC - Significant Ownership

Signature - Title
/s/ Neil Kumar - Neil Kumar, Chief Executive Officer
Location
Palo Alto, CA
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by BridgeBio Pharma LLC.

Significant Ownership of BridgeBio Pharma LLC

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BBOT BridgeBio Oncology Therapeutics, Inc. Common Stock, $0.0001 par value 17.5% $131M 13.9M BridgeBio Pharma LLC Aug 11, 2025

Schedules 13D/G Reported by BridgeBio Pharma LLC:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.